Paul Olson
14Patents
8h-index
8Co-inventors
65Inventor score
Filing activity: Sep 23, 1997 → Jan 6, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8580735B2 | Local complement inhibition for treatment of complement-mediated disorders | Chemistry; Metallurgy | 38 | Active |
| US8168584B2 | Methods of treating age-related macular degeneration by compstatin and analogs thereof | Physics | 32 | Active |
| US9056076B2 | Method of treating age-related macular degeneration comprising administering a compstatin analog | Physics | 28 | Active |
| US9291622B2 | Complement assays and uses thereof | Physics | 17 | Active |
| US8198020B2 | Compositions and methods for enhancing phagocytosis or phagocyte activity | Performing Operations; Transporting | 16 | Expired |
| US7947267B2 | Viral complement control proteins for eye disorders | Chemistry; Metallurgy | 11 | Active |
| US8043609B2 | Viral complement control proteins for eye disorders | Human Necessities | 10 | Active |
| US10407466B2 | Methods of selecting compstatin mimetics | Physics | 10 | Active |
| US9164088B2 | Detecting complement activation | Physics | 3 | Active |
| US8865164B2 | Detecting complement activation | Physics | 2 | Active |
| US9182396B2 | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders | Physics | 1 | Active |
| US11029318B2 | Methods for predicting and treating patients with increased risk of adverse pregnancy outcome | Physics | 0 | Active |
| US6200750A | Mammalian homologous recombination activating sequences and method of identification and their use thereof | Chemistry; Metallurgy | 0 | Expired |
| US9939446B2 | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.